Compared to controls, bipolar disorders showed lower serum glucagon and glucagon-like peptide (GLP-1) levels and higher gastric inhibitory polypeptide (GIP) levels, suggesting alterations in glucose metabolism, which may contribute to the elevated obesity rates in bipolar disorders [71]. This evidence concerns the gene GIP and obesity due to melanocortin 4 receptor deficiency.